Normal antibody response after COVID-19 during treatment with cladribine

Publication date: November 2020Source: Multiple Sclerosis and Related Disorders, Volume 46Author(s): Elisabeth G. Celius
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research